Report Detail

Request for Sample of this report

Service & Software Global Hospital-Acquired Infections Assays Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4764716
    • |
  • 29 October, 2026
    • |
  • Global
    • |
  • 93 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Hospital-Acquired Infections Assays market size was valued at US$ 5127 million in 2025 and is forecast to a readjusted size of US$ 8208 million by 2032 with a CAGR of 7.0% during review period.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
This report is a detailed and comprehensive analysis for global Hospital-Acquired Infections Assays market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hospital-Acquired Infections Assays market size and forecasts, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hospital-Acquired Infections Assays
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hospital-Acquired Infections Assays market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BIOMÉRIEUX, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, BD (Becton, Dickinson and Company), Bioscience, Inc., QIAGEN, Thermo Fisher Scientific Inc., Meridian Bioscience, Inc., Hologic, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hospital-Acquired Infections Assays market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Tests
Urinalysis
Market segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
Market segment by players, this report covers
BIOMÉRIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Hologic, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hospital-Acquired Infections Assays product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Infections Assays, with revenue, gross margin, and global market share of Hospital-Acquired Infections Assays from 2021 to 2026.
Chapter 3, the Hospital-Acquired Infections Assays competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hospital-Acquired Infections Assays market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infections Assays.
Chapter 13, to describe Hospital-Acquired Infections Assays research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hospital-Acquired Infections Assays by Type
    • 1.3.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2025
    • 1.3.3 Blood Tests
    • 1.3.4 Urinalysis
  • 1.4 Global Hospital-Acquired Infections Assays Market by Application
    • 1.4.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Urinary Tract Infections
    • 1.4.3 Pneumonia
    • 1.4.4 Surgical Site Infections
    • 1.4.5 Bloodstream Infections
    • 1.4.6 Other Hospital Infections
  • 1.5 Global Hospital-Acquired Infections Assays Market Size & Forecast
  • 1.6 Global Hospital-Acquired Infections Assays Market Size and Forecast by Region
    • 1.6.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Hospital-Acquired Infections Assays Market Size by Region, (2021-2032)
    • 1.6.3 North America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
    • 1.6.6 South America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 BIOMÉRIEUX
    • 2.1.1 BIOMÉRIEUX Details
    • 2.1.2 BIOMÉRIEUX Major Business
    • 2.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Product and Solutions
    • 2.1.4 BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BIOMÉRIEUX Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Hospital-Acquired Infections Assays Product and Solutions
    • 2.2.4 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 F. Hoffmann-La Roche Ltd.
    • 2.3.1 F. Hoffmann-La Roche Ltd. Details
    • 2.3.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
    • 2.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
  • 2.4 Siemens Healthcare Private Limited
    • 2.4.1 Siemens Healthcare Private Limited Details
    • 2.4.2 Siemens Healthcare Private Limited Major Business
    • 2.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
    • 2.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Siemens Healthcare Private Limited Recent Developments and Future Plans
  • 2.5 BD (Becton, Dickinson and Company)
    • 2.5.1 BD (Becton, Dickinson and Company) Details
    • 2.5.2 BD (Becton, Dickinson and Company) Major Business
    • 2.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
    • 2.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BD (Becton, Dickinson and Company) Recent Developments and Future Plans
  • 2.6 Bioscience, Inc.
    • 2.6.1 Bioscience, Inc. Details
    • 2.6.2 Bioscience, Inc. Major Business
    • 2.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
    • 2.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bioscience, Inc. Recent Developments and Future Plans
  • 2.7 QIAGEN
    • 2.7.1 QIAGEN Details
    • 2.7.2 QIAGEN Major Business
    • 2.7.3 QIAGEN Hospital-Acquired Infections Assays Product and Solutions
    • 2.7.4 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 QIAGEN Recent Developments and Future Plans
  • 2.8 Thermo Fisher Scientific Inc.
    • 2.8.1 Thermo Fisher Scientific Inc. Details
    • 2.8.2 Thermo Fisher Scientific Inc. Major Business
    • 2.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
    • 2.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
  • 2.9 Meridian Bioscience, Inc.
    • 2.9.1 Meridian Bioscience, Inc. Details
    • 2.9.2 Meridian Bioscience, Inc. Major Business
    • 2.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
    • 2.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
  • 2.10 Hologic, Inc.
    • 2.10.1 Hologic, Inc. Details
    • 2.10.2 Hologic, Inc. Major Business
    • 2.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
    • 2.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hologic, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hospital-Acquired Infections Assays Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Hospital-Acquired Infections Assays by Company Revenue
    • 3.2.2 Top 3 Hospital-Acquired Infections Assays Players Market Share in 2025
    • 3.2.3 Top 6 Hospital-Acquired Infections Assays Players Market Share in 2025
  • 3.3 Hospital-Acquired Infections Assays Market: Overall Company Footprint Analysis
    • 3.3.1 Hospital-Acquired Infections Assays Market: Region Footprint
    • 3.3.2 Hospital-Acquired Infections Assays Market: Company Product Type Footprint
    • 3.3.3 Hospital-Acquired Infections Assays Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hospital-Acquired Infections Assays Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Hospital-Acquired Infections Assays Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
  • 6.2 North America Hospital-Acquired Infections Assays Market Size by Application (2021-2032)
  • 6.3 North America Hospital-Acquired Infections Assays Market Size by Country
    • 6.3.1 North America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
    • 6.3.2 United States Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
  • 7.2 Europe Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
  • 7.3 Europe Hospital-Acquired Infections Assays Market Size by Country
    • 7.3.1 Europe Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 7.3.3 France Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region
    • 8.3.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2021-2032)
    • 8.3.2 China Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 8.3.5 India Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
  • 9.2 South America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
  • 9.3 South America Hospital-Acquired Infections Assays Market Size by Country
    • 9.3.1 South America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
    • 10.3.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Hospital-Acquired Infections Assays Market Drivers
  • 11.2 Hospital-Acquired Infections Assays Market Restraints
  • 11.3 Hospital-Acquired Infections Assays Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hospital-Acquired Infections Assays Industry Chain
  • 12.2 Hospital-Acquired Infections Assays Upstream Analysis
  • 12.3 Hospital-Acquired Infections Assays Midstream Analysis
  • 12.4 Hospital-Acquired Infections Assays Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hospital-Acquired Infections Assays. Industry analysis & Market Report on Hospital-Acquired Infections Assays is a syndicated market report, published as Global Hospital-Acquired Infections Assays Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Hospital-Acquired Infections Assays market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo